Skip to content

A Feasibility Study of Virtopsy With Tissue Sampling in Besancon University Hospital

A Feasibility Study of Virtopsy With Tissue Sampling in Besancon University Hospital

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03877900
Acronym
VIRTOPSY+
Enrollment
26
Registered
2019-03-18
Start date
2019-02-28
Completion date
2020-03-06
Last updated
2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Death, Stillbirth and Fetal Death, Termination of Pregnancy

Keywords

post mortem Magnetic Resonance Imaging, stillbirth, fetal death, neonatal death, Minimally Invasive Autopsy, Tissue samplings

Brief summary

The aim of this project is to assess the feasibility of a new local post mortem procedure at Besançon University Hospital : Virtopsy+, magnetic resonance (MR) imaging with tissue sampling of the fetus and newborns.

Detailed description

Minimally invasive autopsy is an alternative for conventional autopsy including post mortem magnetic resonance (MR) imaging and tissues samplings. Because of the raise of parental refusal of autopsy, we intend to assess the local feasibility of a minimally invasive autopsy approach using post mortem MR imaging of fetuses and newborns in order to detect the major pathological abnormalities and/or to determinate the cause of death.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire de Besancon
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 1 Months
Healthy volunteers
No

Inclusion criteria

* stillbirth and fetal deaths over 21 weeks of gestation * termination of pregnancy over 21 weeks of gestation * neonatal death * patient having read the letter of information and signed the consent.

Exclusion criteria

* legal incapacity * limited ability to consent * lack of parental consent

Design outcomes

Primary

MeasureTime frameDescription
Number of virtopsy made completelymonth 12Number of virtopsy made completely (from death until clinical report).

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026